SCHEMBL7622639

SCHEMBL7622639

COc1cc(C)ccc1C(=O)N1CCN(C(Cc2ccc(C#N)c(Oc3cccc(OCCO)c3)c2)c2cnc(C)[nH]2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.38
CASP1 P29466 2/20 0.38
HTT P42858 2/20 0.38
CASP7 P55210 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
FNTA P49354 3/20 0.38
FNTB P49356 3/20 0.38
PGGT1B P53609 3/20 0.38
CBX7 O95931 2/20 0.37
CFTR P13569 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7622760 0.95 MEN1 (0.40) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7632603 0.95 MEN1 (0.43) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7623127 0.94 FNTA (0.37) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7622910 0.92 FNTA (0.38) MEN1MAPK1KMT2AALDH1A1FNTA
SCHEMBL7626194 0.90 CBX7 (0.39) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7628931 0.90 FNTA (0.37) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7624855 0.88 FNTA (0.38) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7683768 0.87 FNTA (0.37) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7683737 0.86 KDM4E (0.39) MEN1MAPK1KMT2AALDH1A1KDM4E
SCHEMBL7621679 0.86 FNTA (0.37) MEN1MAPK1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193283-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-12-19 US claimed
WO-2001060458-A2 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO claimed
US-20020193283-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-12-19 US disclosed
WO-2001060458-A2 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193283-A1 Inhibitors of prenyl-protein transferase FNTA, FNTB, PTAR1 MEN1 3227/4885MAPK1 2662/4885KMT2A 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.